Royalty Pharma Select
Royalty Pharma Select is a private equity fund organized in Ireland and advised by RP Management, LLC. Its adviser reported $0 in gross assets for the fund on Form ADV, filed Mar 28, 2024. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers.
- Gross assets
- $0As reported on Form ADV
- Beneficial owners
- 0
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7)
- Fund type
- Private equity fund
- Domicile
- Ireland
- Auditor
- Ernst & Young
- Administrator
- Ss&c Technologies
- Custodian
- HSBC Bank; Bank of America
- Adviser
- RP Management, LLC · New York, NY · CRD 161569
- Reported on
- Mar 28, 2024Adviser's Form ADV
From SEC filings, not verified. This information is republished from the adviser's Form ADV (Schedule D, Section 7.B.(1)) in the SEC's public Form ADV data, which currently runs through filings made by Dec 26, 2024. Figures are as of the adviser's filing and may have changed since. It is not an offer, solicitation or recommendation, AltMountain has not reviewed the fund, and gross assets are not performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Royalty Pharma Select
What is the minimum investment for Royalty Pharma Select?
Its adviser's Form ADV, filed Mar 28, 2024, does not set a minimum investment for Royalty Pharma Select. The offering documents may still require one.
Who can invest in Royalty Pharma Select?
Royalty Pharma Select is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7).
How large is Royalty Pharma Select?
Its adviser reported $0 in gross assets on Form ADV filed Mar 28, 2024. Gross assets include borrowed money and are not the same as net assets or performance.
Who manages Royalty Pharma Select?
Royalty Pharma Select is advised by RP Management, LLC, based in New York, NY.
Who are Royalty Pharma Select's service providers?
Its Form ADV lists Ernst & Young as auditor and Ss&c Technologies as administrator.